Results 161 to 170 of about 42,993 (314)

Reciprocal molecular and cellular cholinergic working memory impairments in Alzheimer's disease model mice

open access: yesAlzheimer's &Dementia, Volume 22, Issue 5, May 2026.
Abstract INTRODUCTION The degeneration of basal forebrain cholinergic neurons is a key pathophysiological feature of Alzheimer's disease (AD). These cholinergic neurons target cortical neurons including those in the granular retrosplenial cortex (RSG) to facilitate essential cognitive functions.
Chloe I. Rybicki‐Kler   +7 more
wiley   +1 more source

Botulinum Toxin (Dysport) to Prevent Radiation‐Induced Dysfunction of Salivary Glands in Head and Neck Cancer

open access: yesCancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background The main goal of this pilot trial was to investigate the efficacy of botulinum toxin (Dysport) injection before radiotherapy in preserving salivary gland secretion in patients with head and neck cancer. Methods Sixteen patients with head and neck cancer were enrolled, 9 received 50 IU Dysport, and 7 recieved NaCl (0.9%) into the ...
Farshid Farhan   +12 more
wiley   +1 more source

Vibegron for Anticholinergic‐Resistant Pediatric Neurogenic Lower Urinary Tract Dysfunction After Spinal Cord Amputation: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 3, May 2026.
ABSTRACT Introduction Pediatric neurogenic lower urinary tract dysfunction (NLUTD) is commonly managed with anticholinergic agents and clean intermittent catheterization (CIC). However, treatment options are limited for patients who remain resistant to conventional therapy, particularly following spinal cord surgery. Case Presentation A 14‐year‐old boy
Kohei Mori   +7 more
wiley   +1 more source

Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies

open access: yesTherapeutics and Clinical Risk Management, 2019
Christine Jenkins Department of Thoracic Medicine, The George Institute for Global Health and Concord Clinical School, University of Sydney, Sydney, NSW, Australia Abstract: Despite the availability of a range of treatment options and management ...
Jenkins C
doaj  

A Potent, Long-Acting, Orally Active (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxy-2-phenylacetamide:  A Novel Muscarinic M3 Receptor Antagonist with High Selectivity for M3 over M2 Receptors

open access: green, 2000
Morihiro Mitsuya   +13 more
openalex   +1 more source

The pharmacokinetics and safety of vonoprazan in adolescents and children with gastroesophageal reflux disease

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 5, Page 1153-1161, May 2026.
Abstract Objectives Vonoprazan, a potassium‐competitive acid blocker, provides more rapid, potent, and durable elevations in gastric pH than proton pump inhibitors in adults and may be a treatment option for adolescents and children with gastroesophageal reflux disease (GERD).
Darcy J. Mulford   +6 more
wiley   +1 more source

The effect of the muscarinic M 1 receptor antagonist biperiden on cognition in medication free subjects with psychosis

open access: green, 2017
Claudia Vingerhoets   +7 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy